Exact FDA event identifier

Event 73102

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: January 15, 2016
Product types: Drug
Classifications: Class I
Statuses: Terminated
Recalling firm wording: Master Herbs, Inc./Li

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Licorice Coughing Liquid (guaifenesin), 5%, 3.38 fl. oz. (100 ml), OTC, Manufactured by: Ma Ying Long Pharmaceutical Group Co., LTD, Wuhan, China; Distributed by: Master Herbs (USA) Inc., NDC 68511-0460-01

D-0908-2016

Recall number: D-0908-2016
Initiated: January 15, 2016
Classification: Class I
Status: Terminated
Recalling firm: Master Herbs, Inc./Li
Quantity: 6024 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0

Marketed Without An Approved NDA/ANDA: presence of undeclared morphine.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Marketed Without An Approved NDA/ANDA: presence of undeclared morphine.

Code information

all lots

Distribution pattern

Nationwide